Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

The TEMPI syndrome

David B. Sykes, Casey O’Connell, Wilfried Schroyens

Blood (2020) 135 (15): 1199–1203.

https://doi.org/10.1182/blood.2019004216

Published: 2020

Includes: Supplemental data

Journal Articles

Right-to-Left Shunts Are Unexpectedly Common in Adults with HbSS

Bryan Christopher Hambley, MDMPH, Rania Abdul Rahman, MD, Mary Ann O'Riordan, PhD, Nathan Langer, MD, Seth Rotz, MD, Aaron Smith, Robert Schilz, DO/PhD, Mahazarin Ginwalla, MD, Jane A. Little, MD

Blood (2016) 128 (22): 3659.

https://doi.org/10.1182/blood.V128.22.3659.3659

Published: 2016

Journal Articles

Unexplained Hypoxia and Shunting on Echocardiography in Patients with Sickle Cell Disease: A Retrospective Review

Payal C. Desai, MD, Nicole Kendel, MD, Melanie Heinlein, BS, Ying Huang, MA, MS, Eric H. Kraut, MD, Namita Sood, Subha Raman, MD

Blood (2016) 128 (22): 3673.

https://doi.org/10.1182/blood.V128.22.3673.3673

Published: 2016

Journal Articles

TEMPI: A Reversible Syndrome Following Treatment with Bortezomib

Wilfried A. Schroyens, MD, PhD, Casey L. O'Connell, MD, Martha Q Lacy, MD, Eyal C. Attar, MD, Noopur Raje, MD, Bradley G. Somer, MD, Flavia G Rosado, MD, James Hoyer, MD, Donald I. Feinstein, MD, David B. Sykes, MD, PhD

Blood (2012) 120 (21): 986.

https://doi.org/10.1182/blood.V120.21.986.986

Published: 2012

Journal Articles

The TEMPI Syndrome: Telangiectasias, Elevated Erythropoietin and Erythrocytosis, Monoclonal Gammopathy, Perinephric Fluid Collections, and Intrapulmonary Shunting

David B. Sykes, MD, PhD, Wilfried A. Schroyens, MD, PhD, Casey L. O'Connell, MD, Donald I. Feinstein, MD, Hasan Bazari, MD, Douglas M. Dahl, MD, Robert B. Colvin, MD, Bernard P. Paelinck, MD, PhD, Raul N. Uppot, MD, Bart Op de Beeck, MD, William Boswell, MD, Noopur S. Raje, MD, Nancy Lee Harris, MD, Eyal C. Attar, MD

Blood (2011) 118 (21): 1037.

https://doi.org/10.1182/blood.V118.21.1037.1037

Published: 2011

Journal Articles

Use of Bevacizumab in Hereditary Hemorrhagic Telangiectasia

Prithviraj Bose, MD, Jennifer Holter, MD, George Selby, MD

Blood (2008) 112 (11): 3928.

https://doi.org/10.1182/blood.V112.11.3928.3928

Published: 2008

NARROW

The TEMPI syndrome

Right-to-Left Shunts Are Unexpectedly Common in Adults with HbSS

Unexplained Hypoxia and Shunting on Echocardiography in Patients with Sickle Cell Disease: A Retrospective Review

TEMPI: A Reversible Syndrome Following Treatment with Bortezomib

The TEMPI Syndrome: Telangiectasias, Elevated Erythropoietin and Erythrocytosis, Monoclonal Gammopathy, Perinephric Fluid Collections, and Intrapulmonary Shunting

Use of Bevacizumab in Hereditary Hemorrhagic Telangiectasia

Email alerts

ASH Publications

American Society of Hematology

The TEMPI syndrome

Right-to-Left Shunts Are Unexpectedly Common in Adults with HbSS

Unexplained Hypoxia and Shunting on Echocardiography in Patients with Sickle Cell Disease: A Retrospective Review

TEMPI: A Reversible Syndrome Following Treatment with Bortezomib

The TEMPI Syndrome: Telangiectasias, Elevated Erythropoietin and Erythrocytosis, Monoclonal Gammopathy, Perinephric Fluid Collections, and Intrapulmonary Shunting

Use of Bevacizumab in Hereditary Hemorrhagic Telangiectasia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only